"This study evaluated several aspects of the osteogenic effect of hBMP-2 protein injected into quadriceps of female C57B1/6J SCID mice. Mice were euthanized 1, 2, 3, 4, 7, and 14 days postinjection and muscles were collected for several methods of analysis. Hematoxylin and eosin-stained sections of muscles injected with formulation buffer showed no evidence of osteogenesis. In contrast, sections of muscles injected with hBMP-2 showed evidence of endochondral bone formation that progressed to mineralized bone by day 14. In addition, radiographs of mice injected with hBMP-2 showed that much of the quadriceps muscle had undergone mineralization by day 14. Labeled mRNA solutions were prepared and hybridized to oligonucleotide arrays designed to monitor approximately 1300 murine, full-length genes. Changes in gene expression associated with hBMP-2 were determined from time-matched comparisons between buffer and hBMP-2 samples. A gene expression profile was created for 215 genes that showed greater than 4-fold changes at one or more of the indicated time points. One hundred twenty-two of these genes have previously been associated with bone or cartilage metabolism and showed significant increases in expression, e.g., aggrecan (Agc1){up}, runt related transcription factor 2 (Runx2), bone Gla protein 1 (Bglap1), and procollagens type II (Col2a1){up} and X (Col10a1){up}. In addition, there were 93 genes that have not been explicitly associated with bone or cartilage metabolism. Two of these genes, cytokine receptor-like factor-1 (Crlf1){up} and matrix metalloproteinase 23 (Mmp23), showed peak changes in gene expression of 15- and 40-fold on days 4 and 7, respectively. In situ hybridizations of muscle sections showed that Mmp23 and Crlf1 mRNAs were expressed in chondrocytes and osteoblasts, suggesting a role for both proteins in some aspect of cartilage or bone formation"
"BMP-2-induced changes in the expression of gene"
Genes upregulated on Day2-3 versus LSJL:
Cdh11{down}
Cyr61
Bgn
Col5a2
Col3a1
Col12a1
Col6a1(no change on day 1) {up}
Lox
Ptgs2
Timp1
Serpina3n
MMP14
Serpine1
Csf2ra{down}
Junb
Scx
Ccl7
Sod3
Ccnb1{down}
Ccnb2{down}
Crlf1
Ccr1
Vav1{down}
Myog{down}
No Change Day1-3 with some transient upregulation(noted if occurred) versus LSJL:
Sdc2 {down}
Vcam1 (transient on day 2) {down}
Col6a2 {up and down}
Lum {up}
Bsp {up}
Col2a1 (transient decrease on day 3) {down}
Wisp2 {up}
Agc1 {up}
Cd9 {down}
Ptpra {down}
Anxa8 {up}
Socs3 (transient increase on day 2) {up}
Ptpn12 {down}
Generally Downregulated:
MMP2{up}
Col10a1 {up}
Col9a1 {up}
Col15a1 {up}
Eln {up}
Col9a3 {up}
![Full-size image (305 K)](http://ars.els-cdn.com/content/image/1-s2.0-S8756328203001169-gr2.jpg)
"The expression profile for cytokine receptor-like factor 1 (Crlf1) is qualitatively similar to that of Cyr61 and peaks on day 4"<-Crlf1 and Cyr61 may be key components of the chondroinduction by LSJL.
This study has a lot of useful information which will neccessitate returning to it in the future.
Has their been any analysis on the gene MMP-1,MMP-8,MMP-9 and MMP-13. Or any other genes relating to OA
ReplyDeleteMMP-13 for example is a marker for endochondral ossification. You'd have to detect for it specifically in the articular cartilage as you'd want it in the growth plate and bone area.
ReplyDelete